Novo Nordisk has taken the next step in selling its drugs directly to patients by pointing them to telehealth providers that ...

From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D).

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

In separate announcements, Form Health and 9amHealth said they would provide patients seeking support for obesity care with ...